4.09MMarket Cap-0.82P/E (TTM)
0.828High0.771Low9.94KVolume0.812Open0.828Pre Close7.90KTurnover0.21%Turnover RatioLossP/E (Static)4.94MShares3.50052wk High-0.53P/B3.86MFloat Cap0.63152wk Low--Dividend TTM4.67MShs Float246.000Historical High--Div YieldTTM6.85%Amplitude0.500Historical Low0.794Avg Price1Lot Size
NAYA Biosciences Stock Forum
NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
SARASOTA, Fla. and MIAMI, Oct. 31, 2024 (GLOBE NEWSWIRE) -- NAYA Biosciences ("NAYA") (NASDAQ:NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility, today ...
No comment yet